63.76
+0.62
+(0.98%)
At close: January 20 at 6:12:18 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 24 | 18 | 29 | 30 |
Avg. Estimate | 2.58B | 2.6B | 10.28B | 10.6B |
Low Estimate | 2.54B | 2.54B | 10.25B | 10.4B |
High Estimate | 2.82B | 2.68B | 10.31B | 10.72B |
Year Ago Sales | 2.56B | 2.56B | 10.11B | 10.28B |
Sales Growth (year/est) | 0.89% | 1.56% | 1.66% | 3.07% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
EBA.F | -- | -- | -- | -- |
S&P 500 | 9.34% | 11.25% | 14.04% | 13.55% |
Upgrades & Downgrades
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/14/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 1/13/2025 |
Maintains | Citigroup: Buy to Buy | 1/3/2025 |
Reiterates | JMP Securities: Market Perform to Market Perform | 12/16/2024 |
Downgrade | Jefferies: Hold to Underperform | 12/10/2024 |
Maintains | Mizuho: Neutral to Neutral | 11/5/2024 |